Sponsor: 
Seqirus
Administration route: 
Intramuscular injection
Vaccine group: 
All people aged ≥9 years

Registered for use in people aged ≥9 years.

Quadrivalent inactivated influenza vaccine (prepared in cell culture)

Each 0.5 mL monodose pre-filled syringe contains:

  • 15 µg haemagglutinin of each of the 4 recommended influenza virus strains

May contain traces of:

  • propiolactone
  • cetyltrimethylammonium bromide
  • polysorbate 80

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
13 April 2021
Last reviewed: 
13 April 2021